SEC Form 4 · accession 0001012975-15-000245

Larimar Therapeutics, Inc. · LRMR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director · 10% Owner

Period of report

Mar 24, 2015

Accepted (ET)

Mar 25, 2015 · 2:20 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001374690

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Mar 24, 2015	J	1,400,000	$0.00	D	4,202,045	I	See footnote
Common Stock^F4	Mar 24, 2015	J	346,658	$0.00	A	346,658	I	See footnote
Common Stock^F4	Mar 24, 2015	J	346,658	$0.00	D	0	I	See footnote
Common Stock	Mar 24, 2015	J	71,989	$0.00	A	80,097	D

No Table II lines on this filing.

F1Distribution of shares in kind by Third Rock Ventures, L.P. ("TRV") on a pro rata basis to its partners.
F2The shares are directly held by TRV. The general partner of TRV is Third Rock Ventures GP, L.P. ("TRV GP"). The general partner of TRV GP is TRV GP, LLC ("TRV GP LLC") and the Reporting Person is a Manager of TRV GP LLC, as such, each of TRV GP and TRV GP LLC and the Reporting Person exercises shared voting and investment power over the shares held of record by TRV. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any.
F3TRV GP received shares distributed in kind by TRV on a pro rata basis to its partners.
F4The shares are directly held by TRV GP. As such, each of TRV GP LLC and the Reporting Person exercises shared voting and investment power over the shares held of record by TRV GP. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any.
F5Distribution of shares in kind by TRV GP on a pro rata basis to its partners.
F6The Reporting Person received shares distributed in kind by TRV GP on a pro rata basis to its partners.